1. Home
  2. QNTM vs AAME Comparison

QNTM vs AAME Comparison

Compare QNTM & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNTM
  • AAME
  • Stock Information
  • Founded
  • QNTM 1998
  • AAME 1968
  • Country
  • QNTM Canada
  • AAME United States
  • Employees
  • QNTM N/A
  • AAME N/A
  • Industry
  • QNTM
  • AAME Life Insurance
  • Sector
  • QNTM
  • AAME Finance
  • Exchange
  • QNTM NYSE
  • AAME Nasdaq
  • Market Cap
  • QNTM 35.6M
  • AAME 35.1M
  • IPO Year
  • QNTM N/A
  • AAME N/A
  • Fundamental
  • Price
  • QNTM $15.45
  • AAME $1.72
  • Analyst Decision
  • QNTM
  • AAME
  • Analyst Count
  • QNTM 0
  • AAME 0
  • Target Price
  • QNTM N/A
  • AAME N/A
  • AVG Volume (30 Days)
  • QNTM 236.7K
  • AAME 6.7K
  • Earning Date
  • QNTM 05-14-2025
  • AAME 05-13-2025
  • Dividend Yield
  • QNTM N/A
  • AAME 1.19%
  • EPS Growth
  • QNTM N/A
  • AAME N/A
  • EPS
  • QNTM N/A
  • AAME N/A
  • Revenue
  • QNTM N/A
  • AAME $191,355,000.00
  • Revenue This Year
  • QNTM N/A
  • AAME N/A
  • Revenue Next Year
  • QNTM N/A
  • AAME N/A
  • P/E Ratio
  • QNTM N/A
  • AAME N/A
  • Revenue Growth
  • QNTM N/A
  • AAME 2.04
  • 52 Week Low
  • QNTM $2.70
  • AAME $1.25
  • 52 Week High
  • QNTM $23.81
  • AAME $1.99
  • Technical
  • Relative Strength Index (RSI)
  • QNTM 70.61
  • AAME 55.31
  • Support Level
  • QNTM $13.35
  • AAME $1.65
  • Resistance Level
  • QNTM $15.50
  • AAME $1.76
  • Average True Range (ATR)
  • QNTM 1.67
  • AAME 0.06
  • MACD
  • QNTM 0.23
  • AAME -0.01
  • Stochastic Oscillator
  • QNTM 96.46
  • AAME 66.67

About QNTM QUANTUM BIOPHARMA LTD

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

Share on Social Networks: